A few years ago, a leading U.S. hospital system rolled out a predictive AI model for patient readmissions. It had all the right components: a large training dataset, modern architecture and a ...

After delivering one of its strongest quarters ever, pharmaceutical major Lupin Ltd. is preparing for the next leg of growth, anchored in complex generics, respiratory therapies, and targeted ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs to market in a press conference on Wednesday. The Food and Drug ...

CEO Narasimhan says no tariff impact on guidance Top-selling heart drug Entresto sees growth stall Older drugs hit by 'generic erosion' in US market Newer drugs help offset some of the slowdown ...

The last 12 months have been a bit boring for Novartis AG (NYSE:NVS) and have resulted in a lack of my coverage updates on the company. The stock has delivered a total return of around 18% since my ...

CHICAGO, IL / ACCESS Newswire / October 13, 2025 / As Perplexity AI's $34.5 billion bid for Google Chrome reshapes industry conversations, Iron Software is highlighting why enterprises choose ...

Donald Trump's warning of a 100% tariff on branded and patented pharmaceutical products has set the industry buzzing. While Indian pharma exports to the US totalled $10.5 billion in 2024–25, only $1 ...

Abbott ABT has consistently demonstrated strong growth and gained market share within its Nutrition business. Its Diabetes Care business continues to benefit from the growing sales of its flagship, ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

Medications are rarely made from start to finish in a single country; raw materials, active ingredients and final products often cross multiple borders before reaching patients in the U.S., The New ...